Hepatitis C virus (HCV), which was formerly described as the
parenterally transmitted form of non-A, non-B hepatitis (NANBH)1,
becomes a chronic disease in 50% of the cases.
This is an enzyme linked immunosorbent assay using recombinant
proteins derived from core regions of HCV virus to detect the
presence of HCV antibodies in human sera.
2. PRINCIPLE OF THE ASSAY
Multiple epitopes of HCV proteins(Core, NS3, NS4 and NS5) are bound
to the microtiter wells.
When antibodies to HCV are present in the test sample, they react
with recombinant proteins and attach to the solid-phase.
Non-reactive antibodies are removed with the wash buffer.
Human IgGs bound to the antigen are reacted with anti-human IgG
peroxidase conjugate and visualized by subsequent reactions with a
chromogenic substrate. Positive sample generates a medium to dark
blue color.
No color or very pale blue color indicates a negative reaction. The
intensity of the reaction is photometrically quantitated.
3. REAGENTS
Materials provided with the kits:
Item
Description
96T
480T
1
Coating Plate
1
5
2
Negative Control
1ml
5ml
3
Positive Control
1ml
5ml
4
Sample Diluent
12ml
60ml
5
Enzyme Conjugate
12ml
60ml
6
Wash Buffer Concentrate (20x)
30ml
150ml
7
Substrate Solution A
6ml
30ml
8
Substrate Solution B
6ml
30ml
9
Stop Solution
6ml
30ml
10
Plastic Bag
1
5
11
Seal Paper
3
15
12
Manual
1 copy
5 copy
4. Materials required but not provided:
Precision pipettes: 0.02, 0.05, 0.10, 0.15, 0.20, and 1.0 ml.
Disposable pipette tips.
Distilled water.
Humidified Box capable of maintaining 37°C
Absorbent paper or paper towel.
Microtiter plate or strip-well washer
Microtiter plate reader.
5. PRECAUTION FOR USERS
All human source material used in the preparation of this product
was found to be negative for the presence of HIV-1/HIV-2
antibodies, as well as for the hepatitis B surface antigen, using a
commercial licensed method. Nevertheless, because no test method
can offer complete assurance of the absence of infectious agents,
this product should be handled with caution.
Avoid contact of reagents with the eyes and skin. If that occurs,
wash thoroughly with water.
Wear gloves.
Do not pipette by mouth.
Do not smoke.
Dispose all used materials in a suitable biohazardous waste
container. Remains of samples, controls, aspirated reagents and
pipette tips should be collected in a container for this purpose
and autoclaved 1-hour at 121°C or treated with 10% sodium
hypochlorite (final concentration) for 30 min before disposal.
(Remains containing acid must be neutralised prior addition of
sodium hypochlorite).
Adjust washer to the plate used (flat bottom) in order to wash
properly.
Do not mix reagents from different lots.
Do not use reagents after expiration date.
Extreme care should be taken to avoid microbial contamination and
cross contamination of reagents.
Use a new pipette tip for each specimen and each reagent.
Soaps and/or oxidising agents remaining in containers used for the
substrate-TMB solution can interfere with the reaction.
Company Profile
Biovantion Inc is independent from international department of
Bioneovan Co., Ltd., which established in 2 0 0 5, is an in vitro
diagnostic reagents manufacturer engaged in the research,
development, production, and focus on clinical testing for
infectious diseases, such as Hepatitis virus, Noro virus, Parvo
virus test kits, our products include rapid test cassette and Elisa
kits.
All our products have been registered in National Medical Products
Administration of China, in year 2020 we get Certificate of ISO
13485:2016 – QUALITY MANAGEMENT SYSTEMS FOR MEDICAL DEVICES from
SGS. More importantly, we have awarded the registration certificate
from National Medical Products Administration for Diagnostic Kit
for IgM Antibody to COVID-19 and IgG antibody to COVID-19 during
the outbreak in China, and also we developed COVID-19 Antigen test
; Neutralizing Antibody Test, these products selling well all
overthe world